SWITZERLAND – Novartis and Alnylam have announced a collaboration to develop a targeted therapy to promote the regrowth of functional liver cells using Alnylam’s siRNA technology. The study will center…
Read MoreNovartis, Alnylam in collaboration to develop liver medicine
